Development and Validation of a UPLC‐MS/MS Method for the Determination of Apalutamide in Human Plasma and Its Application in a Bioequivalence Study
Biomedical Chromatography · 2026-04 · 40 (4)
DOI: 10.1002/bmc.70400 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 10.03.2026. Verfasst von Qi Wen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Bioanalytical Service Center of Sichuan Institute for Drug Control, Chengdu, China. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Thiohydantoins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
A UPLC‐MS/MS method was developed for determining apalutamide (APT) in human plasma, applied to a bioequivalence study of two tablet formulations. Plasma samples were pretreated by protein precipitation with acetonitrile using APT‐13C‐ d 3 as an internal standard. Separation was on a Waters BEH C18 column with gradient elution (0.1% formic acid in water/acetonitrile) at a flow rate of 0.50 mL/min. ESI (+) and MRM transitions were employed, with m / z 478.1 → 221.2 for APT and m / z 482.2 → 225.3 for APT‐13C‐ d 3 . A crossover bioequivalence study (single‐dose, two‐period) was conducted under fasting or fed conditions. A good linear relationship was observed over the concentration range of 6.00~1200.00 ng/mL. The intrabatch and interbatch accuracy ranged from 95.06% to 104.22% (RSD ≤ 5.05%). The recovery was not less than 102.36%, and no significant matrix effect was observed for APT and APT‐13C‐ d 3 . In both fed and fasting trials, the 90% CI for the geometric mean ratios of C max and AUC 0–72 between the test and reference formulations fell within the range of 80.00%~125.00%. This method is simple, rapid, and accurate, making it suitable for the determination of APT concentration in human plasma. Additionally, the test and reference APT tablets were demonstrated to be bioequivalent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bioanalytical Service Center of Sichuan Institute for Drug Control, Chengdu, China.
- NMPA Center for Innovation and Research in Regulatory Science, Chengdu, China.
ORCID-Profile: Qi Wen
Zitieren
APA
Wen, Q., Cai, J., Yang, M., Xu, X. Y., Wei, B. P., Wu, Q., & Zhao, D. G. (2026). Development and Validation of a UPLC‐MS/MS Method for the Determination of Apalutamide in Human Plasma and Its Application in a Bioequivalence Study. Biomedical Chromatography, 40(4). https://doi.org/10.1002/bmc.70400
Vancouver
Wen Q, Cai J, Yang M, Xu XY, Wei BP, Wu Q, et al. Development and Validation of a UPLC‐MS/MS Method for the Determination of Apalutamide in Human Plasma and Its Application in a Bioequivalence Study. Biomedical Chromatography. 2026;40(4). doi:10.1002/bmc.70400
BibTeX
@article{Wen2026,
author = {Wen, Qi and Cai, Juan and Yang, Min and Xu, Xin-Ying and Wei, Bo-Ping and Wu, Qiang and Zhao, Dai-Guo},
title = {Development and Validation of a UPLC‐MS/MS Method for the Determination of Apalutamide in Human Plasma and Its Application in a Bioequivalence Study},
journal = {Biomedical Chromatography},
year = {2026},
volume = {40},
number = {4},
doi = {10.1002/bmc.70400}
}
EUVIMED